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Summary 
We present evidence that transcriptional activation of 
the human interferon-p (IFNP) gene requires the as- 
sembly of a higher order transcription enhancer com- 
plex (enhanceosome). This multicomponent complex 
includes at least three distinct transcription factors 
and the high mobility group protein HMG l(Y). Both the 
in vitro assembly and in vivo transcriptional activity 
of this complex require a precise helical relationship 
between individual transcription factor-binding sites. 
In addition, HMG l(Y), which binds specifically to three 
sites within the enhancer, promotes cooperative bind- 
ing of transcription factors in vitro and is required for 
transcriptional synergy between these factors in vivo. 
Thus, HMG l(Y) plays an essential role in the assembly 
and function of the IFNp gene enhanceosome. 
Introduction 
Eukaryotic cells are capable of responding specifically to 
large numbers of distinct extracellular signals and environ- 
mental stresses. These responses usually involve signal 
transduction pathways that lead to the activation of spe- 
cific sets of genes. Understanding the mechanisms in- 
volved in this process is complicated by the observation 
that many transcription factors are activated in response 
to avarietyof signals and, once activated, can bind specifi- 
cally to regulatory sequences upstream of a large number 
of different genes (McKnight and Yamamoto, 1992). How- 
ever, only a subset of such genes is activated in response 
to a given signal. Thus, a central problem in signal trans- 
duction is how this specificity is achieved. 
An excellent example of this problem is provided by 
the transcription factor NF-KB, which can be activated in 
response to a large number of extracellular signals and 
environmental stresses (Siebenlist et al., 1994; Baeuerle 
and Henkel, 1994; Thanos and Maniatis, 1995b). In addi- 
tion, a long and growing list of genes containing NF-KB- 
binding sites has been identified. Thus, how does the acti- 
vation of NF-KB by a specific inducer lead to the activation 
of only a subset of the genes containing NF-KB-binding 
sites? 
One answer to this question lies in the organization of 
transcriptional enhancers. Most inducible enhancer ele- 
ments contain multiple, distinct transcription factor-bind- 
ing sites that are part of a combinatorial mechanism that 
relies on cooperative binding of transcriptional activator 
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proteins, transcriptional synergy, or both (for reviews see 
Maniatis et al., 1987; McKnight and Yamamoto, 1992; 
Ptashne, 1992; Tjian and Maniatis, 1994; see also Robert- 
son et al., 1995). A number of studies have demonstrated 
transcriptional synergy with synthetic promoters/en- 
hancers containing multiple copies of transcription factor- 
binding sites, but relatively little is known about the syner- 
gistic interactions in natural transcriptional enhancers. 
An excellent model for studying this problem is provided 
by the virus-inducible enhancer of the human interferon-p 
(IFND) gene (reviewed by Maniatis et al., 1992; Thanos 
et al., 1993; Tjian and Maniatis, 1994). Virus induction 
requires an overlapping set of regulatory elements desig- 
nated positive regulatory domains (PRDs) I through IV. 
PRDII, PRDIII-I, and PRDIV are recognized, respectively, 
by the transcription factors NF-KB, IFN-regulatory factor 1 
(IRF-l), and activating transcription factor 2 (ATF-2)/c-Jun. 
Evidence for the involvement of these activators in virus 
induction of the IFNO gene has been discussed elsewhere 
(Matsuyama et al., 1993; Reis et al., 1994; reviewed by 
Maniatis et al., 1992). The high mobility group protein HMG 
l(Y) also binds to two sites flanking the ATF-2/c-Jun site 
in PRDIV and to a site within PRDII. HMG l(Y) is required 
for the transcriptional activities of both NF-KB and ATF-2/ 
c-Jun in the context of the IFNB gene promoter, and it is 
required for virus induction (Thanos et al., 1993; Du et al., 
1993). However, HMG l(Y) does not itself activate tran- 
scription (Thanos and Maniatis, 1992). 
In vitro DNA binding studies established that HMG l(Y) 
binds to the PRDII and PRDIV elements through contacts 
in the minor groove, while the corresponding activators 
NF-KB and ATF-2/c-Jun bind to these sequences through 
contacts in the major groove. HMG l(Y) interacts specifi- 
cally with both NF-KB and ATF-2 and stimulates the bind- 
ing of both proteins to their binding sites in PRDII and 
PRDIV, respectively. Thus, both PRDII and PRDIV are 
composite elements containing binding sites for a tran- 
scriptional activator and HMG l(Y). Moreover, the func- 
tional synergism between NF-KB and HMG l(Y) at PRDII 
and between ATF-2 and HMG l(Y) at PRDIV appears to 
involve both protein-DNA and protein-protein interactions 
(Thanos and Maniatis, 1992; Du et al., 1993; Kaszubska 
et al., 1993). The three-dimensional structure of the en- 
hancer may therefore be central to the mechanisms re- 
quired for specific activation of the IFND gene, and HMG 
l(Y) may play an essential role in establishing this structure. 
In this paper, we present the results of experiments de- 
signed to test this hypothesis. We show that the activation 
of the IFNp gene in response to virus infection requires 
a specific set of regulatory elements that must be precisely 
arranged on the face of the DNA helix. In addition, we 
show that this arrangement of regulatory sequences is 
required for the cooperative in vitro assembly of an en- 
hancer complex and for the transcriptional activity of this 
complex in vivo. Finally, we show that HMG l(Y) is required 
for the assembly of the IFNB enhancer complex in vitro 
and for transcriptional synergy in vivo. Taken together, 
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Figure 1. Comparison of the Specificity and Strengths of Synthetic 
and Natural Virus-Inducible Enhancers 
Comparison of the transcriptional activities of the intact lFN(3 promoter 
(bottom) with the individual homopolymeric PRDs after transient trans- 
fection into L929 cells. Each of the elements responds to virus infection 
as well as to other extracellular signals. By contrast, the lFN9 promoter 
is induced only by virus. Numbers indicate fold induction. 
these observations strongly support the hypothesis that 
the specificity of the inducible activation of the lFNf3 gene 
promoter requires the assembly of an enhanceosome (a 
term first used by Bazett-Jones et al. [1994]). 
Results 
The Number and Types of Regulatory Elements 
Present in the IFNB Gene Enhancer Determine 
the Specificity and Level of Induction 
The combinatorial nature of the lFNf3 gene enhancer is 
best illustrated by the observation that mutations that inac- 
tivate any one of the PRDs in the context of the lFNf3 
promoter result in a dramatic decrease in the level of virus 
induction. Moreover, a single copy of any PRD is inactive, 
but artificial enhancers can be created by multimerization 
of these elements (for review see Maniatis et al., 1992). 
Synthetic promoters containing multiple copies of individ- 
ual PRDs are not only inducible by virus; they respond to 
other inducers as well (Fan and Maniatis, 1989; Leblanc 
et al., 1990; Duet al., 1993; Thanos and Maniatis, 1995b). 
For example, multiple copies of PRDII are activated by 
virus and by numerous other inducers of NF-KB. However, 
the intact enhancer responds only to virus infection. This 
point is illustrated in Figure 1, where synthetic reporters 
containing multiple copies of PRDIV, PRDIII-I, and PRDII 
were transfected into mouse L929 cells, which were then 
challenged with various inducers. The synthetic promoter 
containing multiple copies of PRDIV is inducible by virus 
and is slightly more inducible by CAMP. Similarly, a pro- 
moter containing multiple copies of the PRDIII-I element 
is inducible by both virus and IFNy (M. Wathelet and T. M., 
unpublished data). Finally, a reporter containing multiple 
copies of PRDII is inducible by tumor necrosis factor a 
(TNFa) and virus infection. Thus, all of the synthetic en- 
hancers respond to virus infection, but they also respond 
to other inducers that activate transcription factors known 
to bind to these sites. 
In sharp contrast, the intact lFN8 promoter is efficiently 
induced by virus infection, but does not respond to any 
of the inducers that act on individual sites (Figure 1). In 
fact, the level of induction observed with the intact en- 
hancer is at least an order of magnitude higher than that 
seen with any of the synthetic enhancers (Figure 1) (see 
also Leblanc et al., 1990). Thus, the specific combination 
and arrangement of regulatory elements in the lFNf3 en- 
hancer allow a highly specific response to virus induction 
and lead to a high level of induction. 
This point was further illustrated by replacement of the 
PRDIV element with PRDII in the context of an otherwise 
intact lFN8 promoter (Figure 2A). The resulting construct 
was transfected into HeLacells, and the activity was exam- 
ined after stimulation with virus, TNFa, IFNT, or TNFa 
plus IFN?. As shown in Figure 2A, a 95-fold induction was 
observed with the wild-type lFN8 promoter, and this pro- 
moter did not respond toTNFa, IFNy, or the combination of 
these cytokines. Remarkably, the replacement of PRDIV 
with PRDIC not only resulted in a decrease in the level 
of virus induction, but the altered promoter was equally 
responsive to TNFa (Figure 2A). Interestingly, the com- 
bined treatment with IFNy and TNFa revealed weak syner- 
gistic interactions between PRDII and PRDI-III, which are 
not evident in the wild-type promoter (Figure 2A). We con- 
clude that the highly specific activation of the lFN6 gene in 
response to virus infection is a consequence of the unique 
arrangement and collection of transcription factor-binding 
sites. 
Virus Induction of the IFNp Gene Enhancer Requires 
Specific Helical Phasing of Individual Transcription 
Factor-Binding Sites 
A striking characteristic of the lFN8 gene enhancer is the 
close spacing of individual regulatory elements. Virtually 
every base pair of the promoter contacts a regulatory pro- 
tein, and every nucleotide is required for maximal levels 
of virus induction. Thus, if protein-protein interactions be- 
tween the activators bound to these elements are essential 
for enhancer function, altering the relative positions of 
these elements on the DNA double helix should adversely 
affect enhancer function. We therefore constructed lFN8 
promoters in which a half- or full-helical turn of DNA was 
inserted between individual PRDs. To avoid the genera- 
tion of fortuitous binding sites for transcriptional activators 
or repressors, we randomized the inserted DNA se- 
quence. Four different isolates with different insertion se- 
quences were selected, linked to the bacterial chlor- 
amphenicol acetyltransferase (CAT) gene, and used in 
transfection experiments. 
Human HeLa cells were transiently transfected with re- 
porter genes bearing either the wild-type lFN8 promoter 
or promoters with insertion mutations. The level of CAT 
activity was determined from cell extracts derived from 
either mock- or Sendai virus-induced cells. Virus induc- 
tion of the wild-type lFN8 promoter resulted in a 156-fold 
increase in CATactivity(Figure2B, line 1). However, when 
slightly more than a half-helical turn (6 bp) was introduced 
between PRDI and PRDII, the level of virus induction was 
only B-fold (Figure 28, line 2). Remarkably, insertion of 10 
bp, which reestablishes the relative positions of binding 
sites on the face of the DNA helix, fully restored the activity 
of the promoter (Figure 28, line 3). Similarly, insertion of 
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Figure 2. The Effects of Substitutions and In- 
sertions on the Function of the IFNb Enhancer 
(A) Substitution of PRDIV by a second PRDII 
alters the specificity of induction. Human HeLa 
cells were transfected with the wild-type IFNb- 
CAT reporter construct or with the indicated 
PRDIV to PRDII substitution. The transfected 
cells were induced with either Sendai virus, 
TNFa, IFNy, or TNFa plus IFNy. Fold induction 
is the ratio of CAT with and without the indi- 
cated inducers. Shown is the average of two 
independent experiments. 
(6) The correct helical phasing of transcription 
factor-binding sites is required for virus mduc- 
tion of the lFNf3 gene enhancer. Human HeLa 
cells were transfected with the wild-type IFNb- 
CAT reporter construct or with the indicated 
insertion mutants. The transfected cells were 
either induced with Sendai virus or mock in- 
duced, and the CAT activity was measured 
from extracts of the transfected cells. Fold virus 
induction is the ratio of CAT with and without 
virus induction. Shown is the average of four Independent experiments. Variability in virus induction among individual experiments and among 
individual constructs in the same experiment was less than 40% and lo%, respectively. 
a half-helical turn between PRDIV and PRDIII virtually in- 
activated the enhancer (Figure 28, line 4) whereas the 
insertion of a full-helical turn again restored transcriptional 
activity (line 5). 
These experiments suggest that the activators specifi- 
cally contact the basal transcription complex or that the 
activators specifically contact each other. With respect to 
the latter possibility, the proteins bound to PRDI and 
PRDIII could interact with those bound to PRDII and 
PRDIV. In fact, IRF-1 has been shown to interact specifi- 
cally and synergize transcriptionally with NF-KB (Garou- 
falis et al., 1994; Neish et al., 1995). Alternatively, it is 
possible that the proteins bound to PRDII interact only 
with those bound to PRDIV. Consistent with this possibility 
is the observation that NF-KB and ATF-2 interact with each 
other in the absence of DNA (Du et al., 1993; Kaszubska 
et al., 1993). 
To test the possibility that the inability of the insertion 
mutants to respond to virus infection is entirely due to 
the misalignment of the PRDII and PRDIV elements, we 
generated the construct shown in line 6 of Figure 28. In 
this promoter, the mutations shown in lines 2 and 4 were 
combined by insertion of 4 bp between PRDIV and PRDIII 
and 6 bp between PRDI and PRDII. This double insertion 
restores the relative positions of the ATF2- and NF-KB- 
binding sites on the face of the DNA helix. However, the 
function of the enhancer is not restored (compare lines 1 
and 6 in Figure 28). Thus, the inability of the insertion 
mutants to respond to virus infection is not simply due to 
the misalignment of PRDII and PRDIV. Taken together, 
these experiments strongly suggest that the proteins 
bound to PRDI-III functionally interact with the activators 
bound to PRDII and PRDIV. Moreover, these interactions 
take place only when the activators are correctly posi- 
tioned on the DNA helix. 
To determine whether the relative positions of the en- 
hancer and the TATA box are required for maximal levels 
of virus induction, we inserted 6 or 10 bp fragments be- 
tween the two elements. As shown in Figure 28 (line 7) 
insertion of a half-helical turn decreased the level of virus 
induction by only 2-fold, and the wild-type level was fully 
restored when a full-helical turn was inserted (line 8). The 
results of these helical phasing experiments indicate that 
enhancer function requires interactions between all the 
activators bound to distinct elements within the enhancer 
and that these interactions depend critically on the relative 
positionsof the binding sites. By contrast, the relativeposi- 
tions of the enhancer and TATA box are less important. 
The latter conclusion is consistent with other studies show- 
ing that the IFNf3 enhancer can function regardless of its 
distance from the TATA box or its orientation with respect 
to the promoter (Goodbourn et al., 1985; Falvo et al., 1995 
[this issue of Cc//j). 
These observations suggest that the activators bound 
to the regulatory elements comprising the IFNp enhancer 
are assembled as a functional unit that interacts optimally 
with the components of the basal transcription complex 
bound to the TATA box. To examine this possibility further, 
we compared the ability of one or two copies of the lFN8 
enhancer to stimulate transcription. We found that report- 
ers containing one or two copies of the enhancer are acti- 
vated to similar levels upon virus infection (data not 
shown). Thus, transcriptional synergism is not observed 
between duplicated enhancers. 
HMG l(Y) Promotes Cooperative Binding of 
Transcription Factors to the IFNP 
Enhancer In Vitro 
Previous studies have shown that the transcription factors 
NF-KB and ATF-2 act together with HMG l(Y) to regulate 
IFN8 gene expression from the PRDII and the PRDIV ele- 
ments (reviewed by Maniatis et al., 1992; Thanos et al., 
1993). In addition, NF-KB and ATF-2/c-Jun specifically in- 
teract in vitro (Du et al., 1993; Kaszubska et al., 1993), 
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Figure 3. The Effect of HMG l(Y) on Specific 
Protein-DNA Interactions In Vitro 
Quantitative DNase I footprinting of the wild- 
type lFN6 promoter using increasing amounts 
of recombinant IRF-1 alone (lanes 4-9) or in 
the presence of a constant amount of ATF-2 
(lanes IO-15), NF-KB (lanes 16-21) NF-KB 
and ATF-2 (lanes 23-26) or HMG l(Y) (lanes 
30-35). HMG l(Y) efficiently recruits IRF-I in 
the presence of both NF-KB and ATF-2 (com- 
pare lanes 23-26 with 36-41 and 42-47). The 
amounts of recombinant proteins used were 1, 
2, 5. 12, 30, and 100 ng for IRF-1; 30 ng for 
NF-KB; 100 ng for ATF-2; and 25 ng (lanes 36- 
41) and 12 ng (lanes 42-47) for HMG I(Y). All 
the proteins were added at the same time. The 
arrow indicates the region in PRDI that is not 
protected by IRF-1 in the presence of NF-KB. 
and HMG l(Y) is required for each of their activities in the 
context of the IFN8 gene enhancer (Thanos and Maniatis, 
1992, 1995b; Du et al., 1993). 
The only known candidate for activation from the 
PRDIII-I element is IRF-1 (Miyamoto et al., 1988). How- 
ever, the results of recent /RF-7 gene knockout studies 
have shown that IRF-1 is not essential for virus induction 
in vivo (Matsuyama et al., 1993; Reis et al., 1994). Thus, 
either IRF-1 is not involved in lFNf3 gene regulation or 
another as yet unidentified factor can substitute function- 
ally. In the absence of other factors capable of activating 
transcription from PRDIII-I, and given the demonstration 
that IRF-1 can interact and synergize with the ~50 subunit 
of NF-KB (Neish et al., 1995), we have used IRF-1 to study 
the in vitro assembly of the lFNf3 gene enhanceosome. 
The transcriptional synergy observed among individual 
regulatory elements of the lFN6 promoter may be due, at 
least in part, to cooperative binding of the corresponding 
transcription factors. To address this possibility, we car- 
ried out in vitro DNA binding experiments with purified 
recombinant proteins. The binding activity of each activa- 
tor was determined separately in titration experiments 
(data not shown), and the appropriate amounts of protein 
were used in each experiment. 
Figure 3 shows that increasing amounts of recombinant 
IRF-1 protein protect the PRDI-III element from DNase I 
cleavage in a concentration-dependent manner (compare 
lane 1 with lanes 4-9). At the highest concentrations of 
IRF-1, protection is extended over PRDII and a portion 
of PRDIV (see also Fujita et al., 1988). When the same 
amounts of IRF-1 are titrated in the presence of a fixed 
amount of ATF-2, both proteins can occupy their binding 
sites simultaneously, as demonstrated by the complete 
protection of both PRDIV and PRDI-III elements (Figure 
3, lanes 14 and 15). No significant binding cooperativity 
is observed between the two proteins. 
When the IRF-1 titration is carried out in the presence 
of a fixed amount of NF-KB (Figure 3, lane 3), a region 
within PRDI (marked by the arrow in lane 16) is no longer 
protected, indicating steric interference between NF-KB 
and IRF-1 within the PRDI site (compare lanes 4-9 with 
16-21). Similarly, IRF-1 inhibited NF-KB binding to PRDII 
in the reciprocal experiment (data not shown). The interfer- 
ence between NF-KB and IRF-1 was not affected by the 
addition of ATF-2 (Figure 3, lanes 23-28). These results 
were surprising, considering that PRDII and PRDI ele- 
ments were shown to function synergistically in vivo (Fan 
and Maniatis, 1989). To determine whether binding of 
HMG l(Y) to the lFNf3 promoter affects the NF-KBIIRF-1 
interference, we titrated IRF-1 in the presence of NF-KB, 
ATF-2, and HMG l(Y). As shown in Figure 3 (lanes 36-41 
and 42-47), the addition of HMG l(Y) along with NF-KS 
and ATF-2 results in the protection of the region within 
PRDI that was blocked by NF-KS. We note that HMG l(Y) 
alone slightly inhibits binding of IRF-1 (Figure 3, lanes 30- 
35). Thus, HMG l(Y) induces a conformational change in 
a multiprotein complex that allows co-occupancy of PRDI 
and PRDII by IRF-1 and NF-KS, respectively. 
The amount of IRF-1 required to fill PRDI was approxi- 
mately the same on naked DNA and in the presence of 
ATF-2, NF-KB, and HMG l(Y) when all of the components 
were added simultaneously (Figure 3). However, a strik- 
ingly different result was obtained when the DNA was pre- 
incubated with HMG l(Y) and then mixed with increasing 
amounts of IRF-1 in the presence of ATF-2 and HMG l(Y). 
Asshown in Figure4A(lanes 14-18) much IessIRF-1 was 
required to fill PRDI compared with the amount required to 
protect PRDI fully in the absence of HMG l(Y) (lanes 
4-8). This HMG l(Y)-dependent cooperative binding of 
PRDI was not observed with a DNA fragment containing 
a 6 bp insertion between PRDII and PRDI (Figure 48). 
HMG l(Y)-dependent cooperative binding to the lFN6 
gene enhancer was also observed with ATF-2 and NF-KB 
alone, and this cooperativity could be abrogated by the 
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Figure 4. Premcubation of HMG l(Y) with the IFNB Enhancer Pro- 
motes the Cooperative Binding of IRF-I 
(A) Binding to the wild-type enhancer. Quantitative DNase I footprinting 
of the wild-type IFNp promoter is shown, using the same amounts of 
recombinant proteins detailed in Figure 3, except for IRF-1, which was 
1, 2.5, 12, and 30 ng. In this experiment, HMG l(Y) (10 ng) was added 
to the DNA 10 min before the addition of the other proteins. 
(B) Binding to the enhancer containing a half-helical turn of DNA in- 
serted between PRDI and PRDII. Quantitative DNase I footprinting 
insertion of a half-helical turn between PRDII and PRDI 
(data not shown). 
In conjunction with other studies showing that HMG l(Y) 
binds specifically to the lFN/3 enhancer, that it promotes 
the binding of both NF-~6 and ATF-2 to their respective 
sites (Thanos and Maniatis, 1992; Du et al., 1993), and 
that it alters the structure of the PRDII-NF-I& complex 
(Falvo et al., 1995), our observations indicate that HMG 
l(Y) plays an essential role in the cooperative assembly 
of a multicomponent IFNP enhancer complex. Moreover, 
this role requires the correct helical phasing of transcrip- 
tion factor-binding sites. 
Synergistic Activation of the IFNP Promoter in 
Cotransfection Experiments Requires the 
Correct Helical Phasing and HMG l(Y) 
To determine whether the cooperative interactions be- 
tween transcriptional activator proteins observed in vitro 
are reflected by synergistic interactions between these 
factors in vivo, we performed cotransfection experiments 
in mouse embryonal P19 cells. These cells were chosen 
because they lack endogenous IRF-1 and NF-KB (Harada 
et al., 1990; Thanos and Maniatis, 1995a). The wild-type 
IFND reporter plasmid was cotransfected into these cells 
along with increasing amounts of expression vectors en- 
coding each activator alone or a combination of all three 
activators. Previous studies have shown that NF-KB and 
IRF-1 synergistically activate the IFNP gene promoter in 
cotransfection experiments (Garoufalis et al., 1994; Neish 
et al., 1995). As shown in Figure 5A, increasing amounts 
of transfected NF-KB (lanes 2-5), IRF-1 (6-9), and ATF-2/ 
c-Jun (1 O-l 3) weakly activated transcription. In sharp con- 
trast, cotransfection of the combination of the expression 
vectors encoding NF-KB, IRF-1, and ATF-2/c-Jun led to 
a synergistic activation of the IFND enhancer (Figure 5A, 
lanes 14-17). For example, transfection of 100 ng of 
NF-KB (Figure 5A, lane 2), IRF-1 (lane 6), or ATF9/c-Jun 
(lane 10) did not stimulate transcription from the intact 
IFNP promoter. However, when the same amounts of the 
activator expression constructs were cotransfected into 
the cells, a 47-fold stimulation of transcription was ob- 
served (Figure 5A, lane 14). More important, when even 
smaller amounts of expression vectors were cotransfected 
(amounts at which virtually no activation was observed 
with each activator alone), a high level of synergy was 
still observed (Figure 5A, lanes 18-21). These results are 
consistent with our in vitro binding experiments showing 
cooperative binding of the IFNP activators. 
To determine whether the helical constraints that inter- 
fere with virus induction and in vitro binding also interfere 
with transcriptional synergy, we examined the effect of 
inserting DNA between PRDI and PRDII on the expression 
of the reporter gene in P19 cells. As shown in Figure 58, 
cotransfection of the IFNP gene activators led to an addi- 
tive activation, as opposed to the synergistic activation 
was performed as in (A), except that the probe contained 6 bp inserted 
between PRDI and PRDII. The amounts of recombinant proteins used 
were as in Figure 3. 
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A 
obtained with the wild-type promoter. We conclude that 
synergistic transcriptional activation in vivo of the natural 
IFNP enhancer requires cooperative binding of multiple 
transcriptional activators, a result consistent with our in 
vitro reconstitution experiments. 
A further test for synergistic interactions between tran- 
scriptional activators on the IFNP gene enhancer was pro- 
vided by a comparison of the transcriptional activities of 
two naturally occurring ATF-2 isoforms generated by alter- 
native splicing within the basic region of the bZlP domain. 
ATF-2,g5 binds specifically to PRDIV and interacts with 
HMG l(Y) in the absence of DNA, and its affinity for PRDIV 
is enhanced by HMG l(Y) (Du and Maniatis, 1994). By 
contrast, ATF-2192 binds to PRDIV, but does not interact 
with either NF-KB or HMG l(Y). HMG l(Y) actually inhibits 
the binding of ATF-2192 to PRDIV (Du and Maniatis, 1994). 
As expected in cotransfection experiments, a high level 
of expression was observed with the ATF-2195 isoform (Fig- 
ure 6,0.25 and 0.5 pg). By contrast, ATF-2192 fails to syner- 
gize with the other IFNP gene activators at the low levels 
of transfected plasmids. The difference between these two 
isoforms does not appear to be a result of differences in the 
level of expression, since the ATF-21&-Jun heterodimer 
stimulates transcription from a reporter containing multi- 
ple PRDIV sites at levels (4-fold) comparable with that of 
the ATF-2,&z-Jun (data not shown). However, at much 
higher concentrations of ATF-2192, the level of expression 
approaches that observed with ATF-2195. These results 
indicate that protein-protein interactions are essential for 
transcriptional synergism at lower levels of activator. At 
very high levels of ATF-219Zr these interactions do not ap- 
pear to be essential for synergism. A precedent for tran- 
scriptional synergism in the absence of cooperative bind- 
Figure 5. Synergistic Activation of the IFNB 
Gene Enhancer in Cultured Mammalian Cells 
Mouse embryonal PI9 cells were cotrans- 
fected with the wild-type lFNj3 reporter plasmid 
(A) or the helical mutated reporter (B), along 
with increasing amounts of expression vectors 
directing the synthesis of p50 plus ~65, ATF-2 
plus c-Jun, and IRF-1. Lane I, 9 pg of empty 
expression vector. Lanes 2-5, increasing 
amounts of an equimolar mixture of p50 and 
~65 expression plasmids (100 ng, 300 ng, 1 
pg, and 3 pg). Lanes 6-9, increasing amounts 
of /RF-7 expression plasmid (100 ng, 300 ng, 
1 pg. and 3 r(g). Lanes 10-13, increasing 
amounts of an equimolar mixture of ATF-2 and 
c-jun expression plasmids (100 ng, 300 ng, 1 
pg. and 3 pg). Lanes 14-17, increasing 
amounts (100 ng, 300 ng, 1 pg, and 3 pg) of 
all the expression vectors. Lanes 18-21, in- 
creasing amounts (3 ng, IO ng, 30 ng, and 100 
ng) of all the expression vectors (A). No syner- 
gisticactivation isobserved with the helical mu- 
tated IFNP promoter (6). The relative CAT activ- 
ities for lanes l-21 in (A) are: 1, 1.3, 2, 4, 9, 
1, 2, 12, 28, 1, 1.5, 3, 5, 47, 135, 256, 540, 2, 
5, 40, and 157. The relative CAT activities for 
lanes I-17 in (B) are: I, I, 2, 2.4, 12, I, 1.5, 
6, 21, I, 1.8, 2, 12, 2, 3, 14, and 67. 
ing has been previously described (Carey et al., 1990). We 
conclude that direct protein-protein interactions between 
ATF-2 and the other components of the enhancer are re- 
quired for synergistic stimulation of transcription when 
ATF-2 is limiting. 
The role of HMG l(Y) in these cotransfection experi- 
ments was established after transfection of all the activa- 
tors in the presence or absence of HMG l(Y) into Drosoph- 
ila Schneider cells. We chose these cells because they 
are highly responsive to exogenous HMG l(Y) (J. Olesen 
and T. M., unpublished data), in contrast to mammalian 
cells, which apparently contain higher levels of endoge- 
nous HMG l(Y). As shown in Figure 7 (lanes 2-4), transfec- 
tionofasmallamountof NF-KB,ATF-~/~-J~~,~~IRF-~ only 
marginally stimulated transcription from the intact IFNP 
promoter. Consistent with our previous observations 
(Thanos and Maniatis, 1992), HMG l(Y) does not stimulate 
transcription on its own (Figure 7, lane 5). When NF-KB, 
IRF-1, and ATF-2/c-Jun were cotransfected with increas- 
ing amounts of HMG I, a strong synergistic activation of 
transcription was observed (Figure 7, compare lanes 6 
and 7-9). We note that the activities of HMG I and HMG 
Y are indistinguishable in all of the functional assays in 
which they have been compared. Importantly, the effect 
of HMG I on the synergistic stimulation of transcription 
critically depends on the correct helical phasing, since the 
addition of HMG I does not promote synergistic activation 
of transcription on a promoter containing 6 bp between 
PRDI and PRDII (Figure 7, compare lanes 15 and 16- 
18). On the contrary, transfected HMG I represses this 
promoter, perhaps by introducing unfavorable DNA con- 
formational changes. Thus, the HMG l(Y) protein is re- 
quired in vivo for the synergistic stimulation of transcription 
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ATFZ+NF-KB+IRFl (pg) 
Figure 6. Direct Protein-Protein interactions between ATF-2 and 
NF-KS Are Required for the Synergistic Activation of the lFN6 Gene 
Promoter 
Mouse embryonal Pi 9 ceils were cotransfected with the wild-type lFN6 
reporter along with increasing amounts (50 ng, 100 ng, 250 ng, and 
500ng)of anequimolar mixof p5Oplusp65, /RF-f. andc-junpluseither 
ATF-2195 (ATF-2/195) or ATF-2,02 (ATF-2/192). Synergistic activation is 
obtained only with the form of ATF-2 that interacts with NF-KS (com- 
pare ATF-2,95 wrth ATF-2&. 
by the lFNf3 gene activators, a result consistent with our 
previous observations (Thanos and Maniatis, 1992; Du et 
al., 1993). 
Reporters -110 IFN-BCAT WT - 110 IFN-DCAT l/H6 
1 2 3 4 5 6 7 8 9 10 II 121314 1516 17 18 
vector + + 
NF-KB + ++++ + + +++ 
ATFYJun + ++++ + ++++ 
IRFl + + +++ + + +++ 
HMG I + l ++ + +++ 
Figure 7. HMG l(Y) Is Required for the Synergistic Activation of the 
lFNf3 Gene Promoter in Drosophila SL2 Cells 
Drosophila SL2 cells were transfected with the reporter construct con- 
taining the lFN6 wild-type (lanes 1-9) or the helical mutant promoters 
(lanes 10-18) along with the indicated Drosophila expression vectors. 
The cells were harvested 48 hr after transfection. and the CAT activity 
was determined. Lanes 1 and 10, 8 ug of empty expression vector; 
lanes 2 and 11, 1 ng of an equimolar mixture of ~50. and p65- 
expressing plasmids; lanes 3 and 12, 1 ug of /RF-1 expression vector; 
lanes 4 and 13,l pg of an equimolar mixture of A TF-2 and c-jun expres- 
sion vectors; lanes 5 and 14, 2 ug of HMG I expression vector. Lanes 
6 and 15 received the indicated expression plasmids in the same 
amounts as lanes 2-5 and 11-14. Lanes 7-9 and 16-18 received 
the same amount of activators as in lanes 6 and 15. plus increasing 
amounts of HMG l-expressing plasmid (1, 2, and 4 pg). 
The human lFNf3 gene is specifically activated in response 
to virus infection. Here, we provide evidence showing that 
this process requires the assembly of an enhanceosome, 
a higher order nucleoprotein complex containing at least 
three types of transcription factors and HMG l(Y). First, 
we show that a specific type and number of transcription 
factor-binding sites and their correct positioning on the 
face of the DNA double helix are required for virus induc- 
tion, synergistic activation by transfected transcriptional 
activators, and the correct assembly of an enhancer com- 
plex in vitro. It is important to note that enhancers inacti- 
vated by the insertion of a half-helical turn can be fully 
reactivated by the addition of a second half-helical turn, 
which reestablishes the normal helical phasing of tran- 
scription factor-binding sites. Second, we show that HMG 
l(Y) is required for the synergistic interactions between 
transcriptional activators in cotransfection experiments in 
vivo and for cooperative interactions in enhanceosome 
assembly in vitro. Strikingly, these functions of HMG l(Y) 
also depend on a specific arrangement of protein-binding 
sites on duplex DNA. 
Multiple protein-protein and protein-DNA interactions, 
and the formation of a highly specific three-dimensional 
structure, provide a self-editing mechanism for ensuring 
that the lFNf3 gene is activated by virus and not by the 
many inducers of NF-KB or of the other transcriptional 
activators that bind to the enhancer. In addition, the co- 
operativity of enhanceosome assembly could determine 
the threshold levels of transcription factors required for 
transcriptional activation, and these levels could be in- 
ducer specific. 
According to the model of enhanceosome structure il- 
lustrated in Figure 8, enhanceosome assembly would re- 
quire the coordinate induction of all the lFNf3 gene activa- 
tors and the presence of HMG l(Y). In addition, specific 
members of each transcription factor family would be se- 
lected for assembly. For example, the PRDII and the 
PRDIV elements are recognized by a number of different 
Rel and bZlP protein family members, respectively. How- 
ever, a number of observations indicate that the p5O/p65 
heterodimer is the optimal Rel family member involved 
in the activation of the lFNf3 gene (Thanos and Maniatis, 
1995a). Similarly, the only proteins detected in virus- 
inducible gel shifts of PRDIV are ATF-2 homodimers and 
ATF-2/c-Jun heterodimers (Du et al., 1993). The JunD- 
FosB heterodimer is capable of binding to PRDIV in vitro, 
but this interaction is strongly inhibited by HMG l(Y) (Du 
et al., 1993). As discussed above and elsewhere (Matsu- 
yama et al., 1993; Reis et al., 1994) the protein(s) required 
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Figure 6. A Modelior the IFNP Gene Enhanceosome 
The enhanceosome is a 60 bp segment of DNA bound to the transcrip 
tional activators NF-KB (p5O/p65), IRF-I, and ATF-2/cJun and HMG 
I(Y). HMG l(Y) is bound to the minor groove of DNA, while the transcrip 
tional activators are bound to the major groove. The binding of HMG 
l(Y) to DNA and to NF-KB and ATF-PlcJun facilitates the conforma- 
tional changes required to form the complex. Once assembled, the 
enhanceosome makes multiple contacts with the basal transcription 
complex. The relative sizes of the proteins and the length of the DNA 
covered are not drawn to scale. 
for activation via PRDI and PRDIII has not been definitively 
identified. For the purpose of discussion here, however, 
IRF-1 is capable of promoting enhanceosome assembly 
in vitro and synergistic interactions in vivo. The formation 
of transcription factor complexes consisting of specific 
members of different families of transcription factors 
could, therefore, provide the meansof integrating multiple 
signaling pathways to target the activation of specific 
genes. 
An essential feature of the model outlined in Figure 8 
is the role of HMG l(Y) (Thanos and Mania& 1992; Du 
et al., 1993). HMG l(Y) binds to the indicated sites in vitro 
and stimulates the binding of both NF-KB and ATF9/c-Jun 
to their respective binding sites. An additional HMG I(Y)- 
binding site was recently identified between the NF-KB 
site and the TATA box, and mutations in this site also 
interfere with HMG l(Y) binding and significantly decrease 
the level of virus induction (D. T. and T. M., unpublished 
data). In an accompanying paper, we examine the struc- 
tural role of HMG l(Y) in the IFNfl gene enhanceosome 
(Falvo et al., 1995). We show that PRDII has an intrinsic 
bend, which is reversed in a dimer-specific fashion by 
NF-KB in conjunction with HMG l(Y). The reversal of this 
bend correlates with the cooperative binding of NF-KB and 
HMG l(Y) to PRDII and with the ability of NF-KB to mediate 
virus induction of the IFNP enhancer. We also show that 
PRDIV is intrinsically bent and that this bend is reversed 
by the binding of ATF-2/c-Jun. The DNA conformation in 
this complex is further modulated by HMG l(Y) (Falvo et 
al., 1995). Thus, the IFNB enhancer appears to be prebent 
in an inactive configuration, and enhanceosome assembly 
leads to conformational changes required for the forma- 
tion of an active complex. 
The multiple protein-protein interactions portrayed in 
the model of Figure 8 are also supported by the ObSeNa- 
tions that NF-KB and ATF9/c-Jun (Du et al., 1993; Kaszub- 
ska et al., 1993; data not shown) and IRF-1 and NF-KB 
(Neish et al., 1995) interact specifically in solution in the 
absenceof DNA. The fact that interactions between NF-KB 
and ATF-2 are stimulated by HMG l(Y) (data not shown) 
is not reflected in the model, since the mechanism of this 
stimulation is not known. The role of specific protein-pro- 
tein interactions between HMG l(Y) and ATF-2 and be- 
tween NF-KB and ATF-2 was directly demonstrated in vivo 
by the inability of the ATF-2192 variant (which does not 
interact with HMG l(Y) or NF-KB) to support synergistic 
activation of the IFNB promoter at lower levels of ATF-2 
expression. 
Generality of Enhanceosomes 
Previous studies have shown that alterations in the relative 
positions of upstream activator-binding sites and core pro- 
moters can adversely affect the activity of some prokary- 
otic (reviewed by Perez-Martin et al., 1994) and eukaryotic 
promoters (Windle and Sollner-Webb, 1986; Xie and Roth- 
blum, 1992; Takahashi et al., 1986; Wu and Berk, 1988). 
However, in early studies, alterations in the helical rela- 
tionships and relative orientations of transcription factor- 
binding sites within eukaryotic enhancers (Fromenthal et 
al., 1988; Ondek et al., 1988) and promoters (McKnight, 
1982) did not significantly affect transcription. In addition, 
multiple copies of transcription factor-binding sites can 
mimic the properties of the intact enhancers and promot- 
ers from which they were derived (McKnight and Yama- 
mote, 1992). Thus, higher order structures were not 
thought to be essential for enhancer and promoter 
function. 
More recent studies, however, have shown that 
changes in the relative positions of transcription factor- 
binding sites within enhancers and promoters can inter- 
fere with transcription (Natesan and Gilman, 1993; Giese 
et al., 1995; Meacocket al., 1994; Reithetal., 1994). More- 
over, proteins that alter DNA structure play an essential 
role in enhancer function (Natesan and Gilman, 1993; 
Giese et al., 1992, 1995; Giese and Grosschedl, 1993; for 
recent review see Grosschedi, 1995) and lead to either 
activation or repression. These individual cases show the 
general importance of higher order structure in enhancer 
function, but they differ significantly from the IFN(3 gene. 
First, the IFNP enhancer contains multiple HMG I(Y)-bind- 
ing sites, while the other enhancers contain a single bind- 
ing site for an architectural protein. Second, HMG l(Y) 
interacts specifically with all three of the transcriptional 
activators that bind to the IFN(3 enhancer. Third, HMG l(Y) 
does not induce a sharp DNA bend when it binds to the 
IFNP enhancer. Rather, HMG l(Y) facilitates the reversal 
of intrinsic DNA bends in PRDII and PRDIV (Falvo et al., 
1995). 
A helical phasing requirement has also been demon- 
strated for TNFa induction of the E-selectin promoter 
(Meacock et al., 1994), a promoter which has been shown 
tocontain HMG I(Y)-bindingsites(Lewisetal., 1994; Whit- 
ley et al., 1994). Mutations in at least one of these sites, 
which abolish HMG l(Y) binding, also adversely affect 
TNFa induction (Lewis et al., 1994; Whitley et al., 1994). 
;FON$ Enhanceosome 
Thus, HMG l(Y)-dependent enhanceosome assembly 
may be a characteristic of many inducible enhancers. 
It is important to note, however, that strict spatial re- 
quirements for transcription factor-binding sites are not a 
property shared by all enhancers. For example, enhancer 
elements can be distributed over many thousands of base 
pairs of DNA (Goto et al., 1989; Corbin and Maniatis, 
1990) and enhancers containing distinct organizations of 
the same binding sites can mediate expression in the Dro- 
sophila neuroectoderm (Gonzalez-Crespo and Levine, 
1994). In fact, the requirements for spatial organization of 
a specific set of enhancer elements can be germ layer- 
specific during embryogenesis (Szymanski and Levine, 
1995). Thus, enhancers can display considerable flexibil- 
ity in their organization, perhaps a reflection of the mecha- 
nisms involved in the creation of novel patterns of gene 
expression during evolution. On the other hand, en- 
hancers required for inducible on/off switches that re- 
spond to distinct extracellular signals may have evolved 
special mechanisms for achieving a high level of speci- 
ficity. 
Experimental Procedures 
Cell Culture and Transfections 
HeLa or PI9 cells were maintained in Dulbecco’s modified Eagle’s 
medium supplemented with 10% fetal bovine serum, antibiotics, and 
L-glutamine (2 mM) in a humidified incubator containing 5% CO,. Tran- 
sient transfections, virus inductions, and CAT assays were performed 
essentially asdescribed previously (Thanos and Maniatis, 1992). HeLa 
cells were transfected with 12 pg of reporter plasmid, 3 ng of CMV- 
S-gal expression vector, and 5 ag of pSP73 carrier plasmid. CAT activ- 
ity was normalized for transfection efficiency by f%galactosidase activ- 
ity (Miller, 1972). P19 cells were plated in 6-well plates 1 day prior to 
transfection and were approximately 30% confluent at the time of 
transfection. The cells were refed with fresh media 3 hr before transfec- 
hon. The transfection cocktail contained 1 ng of reporter plasmid, 100 
ng of CMV+gal, and the indicated amounts of expression vectors. 
The total amount of DNA was kept constant by including the appro- 
priate amounts of the empty expression vector. Inductions with Sendai 
virus, TNFa, IFNy. and CAMP were performed as previously described 
(Fan and Maniatis. 1989; Du et al., 1993; Thanos and Maniatis, 1995a). 
Drosophila melanogaster SL2 cells were maintained in Schneider 
media (GIBCO BRL) and supplemented with 12% fetal calf serum and 
antibiotics at ambient temperature. SL2 cells were plated in 6-well 
dishes 24 hr prior to transfection and transfected by the method of 
Chen and Okayama (1988). Cells were harvested 48 hr posttransfec- 
tion, and CAT activity was determined from cell extracts. Normalization 
for transfection efficiency was performed in all experiments based on 
b-galactosidase activity. The transfection cocktail contained 1 ag of 
the -1 lOIFNf3-CAT reporter construct, 100 ng of hsp82lacZ plasmid 
(which was used as an internal control for transfection efficiency) (Abel 
et al., 1992) and the indicated activators. Vector DNA (pPAC) was 
added as necessary to achieve a constant amount of transfected DNA. 
Plasmid Constructions 
Insertion and substitution mutants of the IFNS promoter were con- 
structed by using the PCR methodology described previously (Thanos 
and Maniatis, 1992) and all mutations were verified by DNA sequenc- 
ing. The PRDIV to PRDII substitution was constructed by replacing 
the ATF-2lcJun binding site (-100 to -91) with PRDII (-64 to -55). 
The I/II6 and l/Ill0 constructs contain insertions between nucleotides 
-65 and -64 from the start site of transcription. The IV/Ill4 and IV/ 
III10 constructs have insertions between -91 and -90. Finally, the II/ 
TATAG and ll/TATAlO contain insertions between -38 and -37. The 
mammalian expression vectors for ~50, ~65, ATF-2, cJun, and IRF-1 
were as previously described (Thanos and Maniatis. 1992, 1995a; Du 
et al., 1993). To construct the Drosophila expression vectors, we 
cloned theentireopen readingframesfor ~50, p65,ATF-2, c-jun, /RF-7, 
and HMG I in the BamHl site of the pPAC plasmid (Krasnow et al., 
1989). 
Assembly of the Transcription Enhancer Complex and DNase I 
Footprinting Assays 
Bacterially expressed and purified ~50, ~65, ATF-2, and HMG l(Y) 
proteins were as described previously (Thanos and Maniatis. 1992; 
Du et al., 1993). To construct the /RF-I expression plasmid. the entire 
open reading frame of /RF-7 was cloned in the bacterial expression 
vector pRSETA (Invitrogen) in-frame with the His-6 moiety. After refold- 
mg, the proteins were concentrated (1 mglml, except p5O/p65. which 
was 300 nglml) and extensively dialyzed in DB buffer without BSA but 
supplemented with 0.3% NP-40 and 0.5 mM PMSF. For the DNase I 
footprinting experiments, IFNp promoter fragments (20,000 cpm) from 
-110 to f20 were end labeled at the noncoding strand and incubated 
with the indicated proteins in 20 ul of DB buffer (10 mM Tris [pH 8.0) 
15 mM HEPES [pH 7.91, 50 mM NaCI, 5 mM MgCI,, I mM d?T) and 
1 mglml BSA, 5% glycerol on ice for 30 min. DNase I (Worthington) 
was diluted in 50 mM CaCl*, 20 mM HEPES (pH 7.9) to.2 nglmlyand 
2 I*I was added directly to the binding reaction. Digestion was allowed 
for 5 min on ice, followed by the addition of 200 PI of stop buffer (2.5 
M ammonium acetate, 25 uglml sonicated salmon sperm DNA). The 
DNAwas ethanol-precipitated, dried, resuspended in 3 nl of formamide 
dye, and loaded on a 6% sequencing gel. 
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